Download PDF
Hamostaseologie 2009; 29(01): 80-87
DOI: 10.1055/s-0037-1616947
Original article
Schattauer GmbH

Antithrombotic therapy in children with venous thromboembolism

J. Yang
1   McMaster University, Department of Pediatrics, Hamilton, Canada
,
N. Paredes
1   McMaster University, Department of Pediatrics, Hamilton, Canada
2   Henderson Research Centre, Hamilton, Canada
,
A. K. C. Chan
1   McMaster University, Department of Pediatrics, Hamilton, Canada
2   Henderson Research Centre, Hamilton, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
08 January 2018 (online)

Also available at
    Permissions and Reprints

Summary

Antithrombotic therapy has recently become more frequent for the treatment of venous thromboembolism (VTE) in the paediatric population. This can be explained by the increased awareness of morbidities and mortalities of VTE in children, as well as the improved survival rate of children with various kinds of serious illnesses. Considering the large number of years a child is expected to survive, associated morbidities such as postthrombotic syndrome and risk of recurrence can significantly impact on the quality of life in children. Therefore, timely diagnosis, evidence-based treatment and prophylaxis strategies are critical to avoid such complications.

This review summarizes the current literature about the antithrombotic treatment for VTE in infants and children. It guides the paediatric medical care provider for making a logical and justifiable decision.

Keywords

Anticoagulation - venous thromboembolism - paediatrics - neonates
 

  • References

  • 1 Andrew M, David M, Adams M. et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251-1257.
    PubMedGoogle Scholar
  • 2 Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96: 939-943.
    PubMedGoogle Scholar
  • 3 Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 73: F163-F167.
    PubMedGoogle Scholar
  • 4 Van Ommen CH, Heijboer H, Büller HR. et al. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139: 676-681.
    CrossrefPubMedGoogle Scholar
  • 5 Massicotte MP, Dix D, Monagle P. et al. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998; 133: 770-776.
    CrossrefPubMedGoogle Scholar
  • 6 Kuhle S, Massicotte P, Chan A, Mitchell L. A case series of 72 neonates with renal vein thrombosis. Data from the 1–800-NO-CLOTS Registry. Thromb Haemost 2004; 92: 729-733.
    PubMedGoogle Scholar
  • 7 Monagle P, Chalmers E, Chan A. et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). Chest 2008; 133: 887S-968S.
    CrossrefPubMedGoogle Scholar
  • 8 Paediatric Stroke Working Group, Royal College of Physicians.. Stroke in childhood. Clinical guidelines for diagnosis, management and rehabilitation. http://www.rcplondon.ac.uk/pubs/books/childstroke/childstroke_guidelines.pdf (Accessed Aug. 2008); 2004
    PubMedGoogle Scholar
  • 9 Roach ES, Golomb MR, Adams R. et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39: 2644-2691.
    CrossrefPubMedGoogle Scholar
  • 10 Gatt ME, Paltiel O, Bursztyn M. Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical-cohort study. Thromb Haemost 2004; 91: 538-543.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Osborne NH, Wakefield TW, Henke PK. Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol. 2008 [Epub ahead of print].
    PubMedGoogle Scholar
  • 12 Lee AY. Cancer and venous thromboembolism: prevention, treatment and survival. J Thromb Thrombolysis 2008; 25: 33-36.
    CrossrefPubMedGoogle Scholar
  • 13 Nelson SM, Greer IA. Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium. Obstet Gynecol Clin North Am 2006; 33: 413-427.
    CrossrefPubMedGoogle Scholar
  • 14 De Stefano V, Rossi E, Leone G. Inherited thrombo philia, pregnancy, and oral contraceptive use: clinical implications. Semin Vasc Med 2003; 3: 47-60.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Battaglioli T, Martinelli I. Hormone therapy and thromboembolic disease. Curr Opin Hematol 2007; 14: 488-493.
    PubMedGoogle Scholar
  • 16 Marchiori A, Mosena L, Prins MH, Prandoni P. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica 2007; 92: 1107-1114.
    CrossrefPubMedGoogle Scholar
  • 17 De Stefano V, Simioni P, Rossi E. et al. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica 2006; 91: 695-698.
    PubMedGoogle Scholar
  • 18 Andrew M, Paes B, Milner R. et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-172.
    PubMedGoogle Scholar
  • 19 Andrew M, Paes B, Milner R. et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-1657.
    PubMedGoogle Scholar
  • 20 Andrew M, Vegh P, Johnston M. et al. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005.
    PubMedGoogle Scholar
  • 21 Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12: 95-104.
    CrossrefPubMedGoogle Scholar
  • 22 Stein PD, Kayali F, Olson RE. Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr 2004; 145: 563-565.
    CrossrefPubMedGoogle Scholar
  • 23 Monagle P, Ignjatovic V, Furmedge J. et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95: 362-372.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Chan AKC, Black L, Ing C. et al. Utility of aPTT in monitoring unfractionated heparin in children. Thromb Res 2008; 122: 135-136.
    CrossrefPubMedGoogle Scholar
  • 25 Ginsberg JS, Kowalchuk G, Hirsh J. et al. Heparin effect on bone density. Thromb Haemost 1990; 64: 286-289.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Newall F, Barnes C, Ignjatovic V, Monagle P. Heparin-induced thrombocytopenia in children. J Paediatr Child Health 2003; 39: 289-292.
    CrossrefPubMedGoogle Scholar
  • 27 Schmugge M, Risch L, Huber AR. et al. Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics 2002; 109: E10.
    CrossrefPubMedGoogle Scholar
  • 28 Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature. Thromb Haemost 2004; 91: 719-724.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Risch L, Huber AR, Schmugge M. Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thromb Res 2006; 118: 123-135.
    CrossrefPubMedGoogle Scholar
  • 30 Hassell K. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy. Chest 2005; 127: 1S-8S.
    CrossrefPubMedGoogle Scholar
  • 31 Andrew M, Ofosu F, Schmidt B. et al. Heparin clearance and ex vivo recovery in newborn piglets and adult pigs. Thromb Res 1988; 52: 517-527.
    CrossrefPubMedGoogle Scholar
  • 32 McDonald MM, Jacobson LJ, Hay Jr WW, Hathaway WE. Heparin clearance in the newborn. Pediatr Res 1981; 15: 1015-1018.
    CrossrefPubMedGoogle Scholar
  • 33 Andrew M, deVeber G. Pediatric thromboembolism and stroke protocols. 1st ed. Hamilton: B.C. Decker Inc.; 1997
    Google Scholar
  • 34 Raschke RA, Reilly BM, Guidry JR. et al. The weight-based heparin dosing nomogram compared with a „standard care“ nomogram. A randomized controlled trial. Ann Intern Med 1993; 119: 874-881.
    CrossrefPubMedGoogle Scholar
  • 35 Weitz JI. Low-molecular-weight heparins. N Eng J Med 1997; 337: 688-698.
    CrossrefPubMedGoogle Scholar
  • 36 Young E, Wells P, Holloway S. et al. Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin. Thromb Haemost 1994; 71: 300-304.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Massicotte P, Adams M, Marzinotto V. et al. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996; 128: 313-318.
    CrossrefPubMedGoogle Scholar
  • 38 Massicotte P, Julian JA, Marzinotto V. et al. Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patients. Thromb Res 2003; 109: 93-99.
    CrossrefPubMedGoogle Scholar
  • 39 Nohe N, Flemmer A, Rümler R. et al. The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. Eur J Pediatr 1999; 158: S134-S139.
    CrossrefPubMedGoogle Scholar
  • 40 Kuhle S, Massicotte P, Dinyari M. et al. Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events. Thromb Haemost 2005; 94: 1164-1171.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 41 Dix D, Andrew M, Marzinotto V. et al. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr 2000; 136: 439-445.
    CrossrefPubMedGoogle Scholar
  • 42 Massicotte P, Julian JA, Gent M. et al. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 2003; 109: 85-92.
    CrossrefPubMedGoogle Scholar
  • 43 Van Ryn-McKenna J, Cai L, Ofosu FA. et al. Neutralization of enoxaparine-induced bleeding by protamine sulfate. Thromb Res 1990; 63: 271-274.
    PubMedGoogle Scholar
  • 44 Massonnet-Castel S, Pelissier E, Bara L. et al. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation. Haemostasis 1986; 16: 139-146.
    PubMedGoogle Scholar
  • 45 Malowany JI, Monagle P, Knoppert DC. et al. Enoxaparin for neonatal thrombosis: A call for a higher dose for neonates. Thromb Res 2008; 122: 826-830.
    CrossrefPubMedGoogle Scholar
  • 46 Streif W, Andrew M, Marzinotto V. et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999; 94: 3007-3014.
    PubMedGoogle Scholar
  • 47 Newall F, Barnes C, Savoia H. et al. Warfarin therapy in children who require long-term total parenteral nutrition. Pediatrics 2003; 112: e386.
    CrossrefPubMedGoogle Scholar
  • 48 Andrew M, Marzinotto V, Brooker LA. et al. Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 1994; 71: 265-269.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 49 Taybi H, Capitanio MA. Tracheobronchial calcification: an observation in three children after mitral valve replacement and warfarin sodium therapy. Radiology 1990; 176: 728-730.
    CrossrefPubMedGoogle Scholar
  • 50 Barnes C, Newall F, Ignjatovic V. et al. Reduced bone density in children on long-term warfarin. Pediatr Res 2005; 57: 578-581.
    CrossrefPubMedGoogle Scholar
  • 51 Massicotte P, Julian J, Webber C, Charpentier K. Osteoporosis: A potential complication of long term warfarin therapy. Thromb Haemost 1999; 80: 1333a.
    PubMedGoogle Scholar
  • 52 Zigman A, Yazbeck S, Emil S, Nguyen L. Renal vein thrombosis: a 10-year review. J Pediatr Surg 2000; 35: 1540-1542.
    CrossrefPubMedGoogle Scholar
  • 53 Duncan BW, Adzick NS, Longaker MT. et al. In utero arterial embolism from renal vein thrombosis with successful postnatal thrombolytic therapy. J Pediatr Surg 1991; 26: 741-743.
    CrossrefPubMedGoogle Scholar
  • 54 Andrew M, Brooker LA. Hemostatic complications in renal disorders of the young. Pediatr Nephrol 1996; 10: 88-99.
    CrossrefPubMedGoogle Scholar
  • 55 Bökenkamp A, von Kries R, Nowak-Göttl U. et al. Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome. Eur J Pediatr 2000; 159: 44-48.
    CrossrefPubMedGoogle Scholar
  • 56 Lau KK, Stoffman JM, Williams S. et al. Neonatal renal vein thrombosis: review of the English-language literature between 1992 and 2006. Pediatrics 2007; 120: e1278-e1284.
    CrossrefPubMedGoogle Scholar
  • 57 Schwartz DS, Gettner PA, Konstantino MM. et al. Umbilical venous catheterization and the risk of portal vein thrombosis. J Pediatr 1997; 131: 760-762.
    CrossrefPubMedGoogle Scholar
  • 58 Morag I, Epelman M, Daneman A. et al. Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr 2006; 148: 735-739.
    CrossrefPubMedGoogle Scholar
  • 59 Kim JH, Lee YS, Kim SH. et al. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 2001; 219: 645-650.
    CrossrefPubMedGoogle Scholar
  • 60 Heller C, Heinecke A, Junker R. et al. Cerebral venous thrombosis in children: a multifactorial origin. Circulation 2003; 108: 1362-1367.
    CrossrefPubMedGoogle Scholar
  • 61 Wu YW, Miller SP, Chin K. et al. Multiple risk factors in neonatal sinovenous thrombosis. Neurology 2002; 59: 438-440.
    CrossrefPubMedGoogle Scholar
  • 62 DeVeber G, Andrew M, Adams C. et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345: 417-423.
    CrossrefPubMedGoogle Scholar
  • 63 DeVeber G. Arterial ischemic strokes in infants and children: an overview of current approaches. Semin Thromb Hemost 2003; 29: 567-573.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 64 Fitzgerald KC, Williams LS, Garg BP. et al. Cerebral sinovenous thrombosis in the neonate. Arch Dis Child 2006; 63: 405-409.
    PubMedGoogle Scholar
  • 65 Wu YW, Hamrick SE, Miller SP. et al. Intraventricular hemorrhage in term neonates caused by sinovenous thrombosis. Ann Neurol 2003; 54: 123-126.
    CrossrefPubMedGoogle Scholar
  • 66 Moharir M, Shroff M, MacGregor D. et al. Clinical and radiographic features of thrombosis propagation in neonatal and childhood cerebral sinovenous thrombosis. Ann Neurol 2006; 60: S141.
    CrossrefPubMedGoogle Scholar
  • 67 Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics 1995; 96: 291-294.
    PubMedGoogle Scholar
  • 68 Nowak-Göttl U, Junker R, Kreuz W. et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001; 97: 858-862.
    CrossrefPubMedGoogle Scholar
  • 69 Kearon C, Gent M, Hirsh J. et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Eng J Med 1999; 340: 901-907.
    CrossrefPubMedGoogle Scholar
  • 70 Athale UH, Chan AK. Thrombosis in children with acute lymphoblastic leukemia. Part II, Pathogenesis of thrombosis in children with acute lympho blastic leukemia: effects of the disease and therapy. Thromb Res 2003; 111: 199-212.
    CrossrefPubMedGoogle Scholar
  • 71 Nowak-Göttl U, Heinecke A, von Kries R. et al. Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration. Thromb Res 2001; 103: 165-172.
    CrossrefPubMedGoogle Scholar
  • 72 Einhäupl KM, Villringer A, Meister W. et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597-600.
    CrossrefPubMedGoogle Scholar
  • 73 De Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30: 484-488.
    CrossrefPubMedGoogle Scholar
  • 74 DeVeber G, Chan A, Monagle P. et al. Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch Neurol 1998; 55: 1533-1537.
    CrossrefPubMedGoogle Scholar
  • 75 Sébire G, Tabarki B, Saunders DE. et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005; 128: 477-489.
    CrossrefPubMedGoogle Scholar
  • 76 Monagle P, Adams M, Mahoney M. et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 763-766.
    CrossrefPubMedGoogle Scholar
  • 77 Mitchell L, Andrew M, Hanna K. et al. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study. Thromb Haemost 2003; 90: 235-244.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 78 Elhasid R, Lanir N, Sharon R. et al. Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia. Blood Coagul Fibrinolysis 2001; 12: 367-370.
    CrossrefPubMedGoogle Scholar
  • 79 Nowak-Göttl U, Münchow N, Klippel U. et al. The course of fibrinolytic proteins in children with malignant bone tumours. Eur J Pediatr 1999; 158: S151-S153.
    CrossrefPubMedGoogle Scholar
  • 80 Monagle P, Karl TR. Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2002; 5: 36-47.
    CrossrefPubMedGoogle Scholar
  • 81 Monagle P, Cochrane A, McCrindle B. et al. Thromboembolic complications after fontan procedures--the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg 1998; 115: 493-498.
    CrossrefPubMedGoogle Scholar
  • 82 Kaulitz R, Ziemer G, Rauch R. et al. Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis). J Thorac Cardiovasc Surg 2005; 129: 569-575.
    CrossrefPubMedGoogle Scholar
  • 83 Seipelt RG, Franke A, Vazquez-Jimenez JF. et al. Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches. Ann Thorac Surg 2002; 74: 556-562.
    CrossrefPubMedGoogle Scholar